Sobi Q2 2026 report: Significant growth with important pipeline progress
STOCKHOLM, July 16, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the second quarter of 2026. Second Quarter 2026 Total revenue increased 29 per cent at CER (constant exchange rates), 27 per cent at actual rates, to SEK 7,842 M (6,175)...
STOCKHOLM, July 16, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the second quarter of 2026. Second Quarter 2026 Total revenue increased 29 per cent at CER (constant exchange rates), 27 per cent at actual rates, to SEK 7,842 M (6,175)...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.